$26.41
1.38%
NYSE, Nov 16, 04:00 pm EST. Closed.
ISIN
US28414H1032
Symbol
ELAN

Elanco Animal Health, Inc. Stock price

$26.41
+2.86 12.14% 1M
+6.48 32.51% 6M
+3.78 16.70% YTD
+4.99 23.30% 1Y
+14.92 129.85% 3Y
-5.88 18.21% 5Y
-9.59 26.64% 10Y
-9.59 26.64% 20Y
NYSE, Closing price Mon, Nov 16 2026
-0.37 1.38%
ISIN
US28414H1032
Symbol
ELAN
Industry

Is Elanco Animal Health, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,087 stocks worldwide.

Key metrics

Basic
Market capitalization
$13.2b
Enterprise Value
$16.6b
Net debt
$3.4b
Cash
$530.0m
Shares outstanding
499.6m
Valuation
P/E
negative
P/S | estimate
2.6 | 2.5
EV/Sales | estimate
3.3 | 3.1
EV/FCF | ex SBC
43.8 | 54.4
P/B
2.0
Financial Health
Equity Ratio
49.0%
Return on Equity
-3.5%
ROCE
2.8%
ROIC
3.6%
Debt/Equity
0.6
Share-Based Compensation & Dilution
SBC | % of Revenue
$74.0m | 1.5%
SBC as % of FCF
19.5%
SBC Growth 1Y
13.8%
Share Count Growth 1Y
0.6%
Shareholder Yield
-0.6%
Financials
Revenue | estimate
$5.0b | $5.3b
EBITDA
$889.0m
EBIT
$333.0m
Net Income
$-199.0m
Free Cash Flow | ex SBC
$379.0m | $305.0m
Growth
Revenue | estimate
12.0% | 11.9%
EBITDA
20.8%
EBIT
59.3%
Net Income
-145.9%
Free Cash Flow
9.2%
Margin
Gross
55.4%
EBITDA
17.7%
EBIT
6.6%
Net
-4.0%
Free Cash Flow | ex SBC
7.6% | 6.1%
More
EPS
$-0.4
FCF per Share
$0.8
Short interest
10.5%
Employees
10k
Rev per Employee
$490.0k

Elanco Animal Health, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

22 Analysts have issued a Elanco Animal Health, Inc. forecast:

19x Buy
86%
3x Hold
14%

Analyst Opinions

22 Analysts have issued a Elanco Animal Health, Inc. forecast:

Buy
86%
Hold
14%

Elanco Animal Health, Inc. Events

Past Events
NOV
9
2026 UBS Global Healthcare Conference
8 days ago
NOV
6
Q3 2026 Earnings Call
11 days ago
SEP
22
Bank of America Global Healthcare Conference 2026
about 2 months ago
SEP
15
Morgan Stanley 24th Annual Global Healthcare Conference
2 months ago
AUG
5
Q2 2026 Earnings Call
3 months ago
JUN
2
46th Annual William Blair Growth Stock Conference
6 months ago
MAY
27
Stifel Jaws & Paws Conference 2026
6 months ago
MAY
6
Q1 2026 Earnings Call
7 months ago
MAR
17
2026 KeyBanc Capital Markets Healthcare Forum
8 months ago
MAR
11
Leerink Global Healthcare Conference 2026
8 months ago
MAR
10
Barclays 28th Annual Global Healthcare Conference
8 months ago
MAR
2
TD Cowen 46th Annual Health Care Conference
9 months ago
FEB
26
BofA Securities Animal Health Summit
9 months ago
FEB
24
Q4 2025 Earnings Call
9 months ago
JAN
13
44th Annual J.P. Morgan Healthcare Conference
10 months ago
DEC
9
Analyst/Investor Day - Elanco Animal Health Incorporated
11 months ago
DEC
4
Piper Sandler 37th Annual Healthcare Conference
12 months ago
DEC
3
Evercore 8th Annual Healthcare Conference
12 months ago
NOV
5
Q3 2025 Earnings Call
about one year ago

Financial data from Elanco Animal Health, Inc.

Jun '26
+/-
%
5,020 5,020
12% 12%
100%
- Direct Costs 2,241 2,241
10% 10%
45%
2,779 2,779
13% 13%
55%
- Selling and Administrative Expenses 1,519 1,519
11% 11%
30%
- Research and Development Expense 371 371
5% 5%
7%
889 889
21% 21%
18%
- Depreciation and Amortization 556 556
6% 6%
11%
EBIT (Operating Income) EBIT 333 333
59% 59%
7%
Net Profit -199 -199
146% 146%
-4%

In millions USD.

Don't miss a Thing! We will send you all news about Elanco Animal Health, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Elanco Animal Health, Inc. Stock News

Neutral
PRNewsWire
●
11 days ago
Accelerated Price, Organic Constant Currency Revenue Growth, and Gross Margin Expansion; Raising Full Year Outlook and Innovation Target; Achieved 2.9x Net Leverage Ratio Milestone Third Quarter 2026 Financial Results: Revenue of $1.265 billion, an increase of 11% year-over-year; 9% organic constant currency growth Reported Net Income of $18 million, Adjusted Net Income of $136 million Adjusted...
Neutral
PRNewsWire
●
11 days ago
Latest U.S. Survey of 2,000+ Consumers Shows 93% of Pet Owners Maintained or Increased Pet Spending in Past Three Months, Omnichannel Shift Redefines Purchasing INDIANAPOLIS, Nov. 6, 2026 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN), today released findings from its latest U.S. consumer research, demonstrating that pet owners continue to fiercely protect health spending for th...
More Elanco Animal Health, Inc. News

Company Profile

Elanco Animal Health, Inc. engages in the innovation, development, manufacture and market products for companion and food animals. It offers products through the following four categories: Companion Animal Disease Prevention, Companion Animal Therapeutics, Food Animal Future Protein & Health, and Food Animal Ruminants & Swine. The Companion Animal Disease Prevention category engages in the broadest parasiticide portfolios in the companion animal sector based on indications, species and formulations, with products that protect pets from worms, fleas and ticks. The Companion Animal Therapeutics category provides the details of broad pain and osteoarthritis portfolio across species, modes of action, indications and disease stages. The Food Animal Future Protein & Health category includes vaccines, nutritional enzymes and animal-only antibiotics, serves the growing demand for protein and includes innovative products in poultry and aquaculture production, where demand for animal health products is outpacing overall industry growth. It also focuses on developing functional nutritional health products that promote food animal health, including enzymes, probiotics and prebiotics. The Food Animal Ruminants & Swine category develops animal food products used in ruminant and swine production. The company was founded on May 3, 2018 and is headquartered in Greenfield, IN.

Head office United States
CEO Mr. Simmons
Employees 9,650
Founded 1954
Website www.elanco.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today